Things changed one day last fall when his wife shared her blood test results
Risk Assessment: Evaluate the patient's obesity risk embedded in their genetics, gut microbiome, and insulin metabolism
The listing includes one 10mg lyophilized retatrutide vial (98% purity per supplier batch specification), one 5ml vial of bacteriostatic water, two 3ml Luer-lock syringes for reconstitution, and five 1ml graduated syringes components supplied together for laboratory handling
The calculus is straightforward
According to research by University College London (UCL),1.6 million UK adults used weight-loss jabs in 2025, with most buying through private prescriptions
Weight Loss Distribution The results weren't just impressive on averagethey were consistent across the patient population: Weight Loss Thresholds Achieved (12mg dose): 5% weight loss: 94.6% of participants 10% weight loss: 91.3% of participants 15% weight loss: 83.2% of participants 20% weight loss: 73.4% of participants 25% weight loss: 58.6% of participants For comparison, FDA approval for obesity medications typically requires that at least 35% of patients achieve 5% weight loss
